Institute of Transfusion Medicine and Transplant Engineering’s Post

Precision medicine innovation and the role of ecosystems This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems, examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK's leading property developer to the science and technology sectors, Bruntwood SciTech. In the whitepaper, you will discover: - The evolution of precision diagnostics for oncology in the North West of England - How life science ecosystems enable key breakthroughs in precision medicine - A view into the future of precision medicine developments. Download Whitepaper https://lnkd.in/eKYQ5d-M Brought to you by Bruntwood SciTech #PrecisionMedicine #DrugDiscovery #Diagnostics

APIS has been featured in the Bruntwood SciTech and Drug Discovery World whitepaper: 'Fuelling the future: Precision medicine innovation and the role of ecosystems' Check it out below!

👨🔬Meet Dr. Ben J. Gu, Principal Science and Head of the Innate Phagocytosis Lab at the Florey Institute, University of Melbourne. Established in 2012, his lab focuses on pioneering novel diagnostic tools and therapeutic drugs for Alzheimer’s disease. We're honored to support their groundbreaking research with our INFORS HT bioreactors. "Our lab has been using INFORS HT bioreactors for nearly 10 years, from Minifors to Labfors. With their state-of-the-art design, we can easily optimize culture conditions for various applications. The stability and reliability of each batch are unmatched, allowing us to prepare our work as scheduled." - Dr. Ben Gu, Innate Phagocytosis Lab. 🔗Want to learn more about our bench-top bioreactors? https://ow.ly/F4RK50SnbTu #InforsHT #Bioreactors #ScientificInnovation #LabEfficiency #ResearchSupport #AlzheimersResearch #CustomerSatisfaction #ScientificBreakthroughs

It has been a very productive few days for my clinical research team. Here featuring our first publication on looking at the Real-World efficacy of Computer Assisted Diagnosis and characterisation (CADx) in identifying polyps which might one day assist endoscopist to be more confident to Resect-and-Discard, a means to reduce healthcare cost while still effectively reduce post colonoscopy colon cancer for our patients. This is also a proper foray into cross collaboration with the University of Copenhagen (Københavns Universitet) and the Center for Surgical Science (CSS), thanks to a good friend, Professor Ismail Gogenur. Kudos to young surgical trainees, Brittany and Gabrielle for getting this across the line promptly. Appreciate the SKH senior management (Eng Kiong Teo Pon Poh Hsu) along with Medtronic trust and support in the CO-PILOT study (A Comprehensive Review of the Impact of a COmPuter-aIded reaL-time pOlyp deTection System on Adult Colonoscopy (COPILOT Study) - a Single Institution Adoption Experience) (clinicaltrials.gov reference: NCT05822895) Sengkang General Hospital

🔔Have you seen this week's special Cell Transplant and Regenerative Medicine Society (CTRMS)-themed #TTSPulse? Hear from CTRMS leadership about the organization's mission and future goals, as well as research highlights. Read here 👉 https://lnkd.in/gGSRjy6B

🚀New cutting-edge laboratory for preclinical stroke research - New capacities for ETAP-Lab! 🧠   To support our growth and our preclinical research activities for our customers, we have invested in new facilities in 2024 in France! We can now produce 3 times more neurovascular diseases studies in 700m² of installations, including 400m² of laboratories with modern equipments to offer the best of our expertise. Our lab is at the very best heart of the research complex supported by CYCERON, the #ESR3P and BB@C institute   👉More details revealed in our website: https://lnkd.in/gn6ttghk   #StrokAlliance #strokeresearch #preclinicalscience #laboratory

Great news! 🎉 The Ubbo Emmius Foundation (UEF) has funded HTRIC €18.4 million euros. This funding supports innovative research in health technology and strengthens the Northern Netherlands as a leading region in this field. Being a partner of HTRIC we are very happy with this development. Our dean Wiro Niessen says: “This investment enables us to accelerate realizing our ambition: a healthier future for all. HTRIC combines science, technology and practice to bring medical innovations to patients quickly and effectively.” With a focus on research themes such as molecular diagnostics, imaging, targeted therapy, and materials, HTRIC aims to create impactful solutions like light-activated cancer therapy and minimally invasive implants. These advancements bring us closer to safer, more effective, and personalized patient care. #HealthTech #Innovation #Collaboration #HTRIC #UMCG #UbboEmmiusFoundation 

We are excited to share our latest scientific publication “𝗖𝗵𝗮𝗺𝗯𝗲𝗿-𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁𝗶𝗹𝗲 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲𝘀 𝗼𝗳 𝗮𝘁𝗿𝗶𝗮𝗹 𝗮𝗻𝗱 𝘃𝗲𝗻𝘁𝗿𝗶𝗰𝘂𝗹𝗮𝗿 𝗵𝗶𝗣𝗦𝗖-𝗰𝗮𝗿𝗱𝗶𝗼𝗺𝘆𝗼𝗰𝘆𝘁𝗲𝘀 𝘁𝗼 𝗚𝗣𝗖𝗥 𝗮𝗻𝗱 𝗶𝗼𝗻 𝗰𝗵𝗮𝗻𝗻𝗲𝗹 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱𝘀: 𝗔 𝗺𝗶𝗰𝗿𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝘀𝘆𝘀𝘁𝗲𝗺 𝗳𝗼𝗿 𝗰𝗮𝗿𝗱𝗶𝗮𝗰 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁” in collaboration with Axol Bioscience Ltd. and Nanion Technologies! Read the article to learn more about axoCells™ human iPSC-derived atrial and ventricular cardiomyocytes and their chamber-specific responses to GPCR and ion channel modulators on contractile level. By focusing on the unique properties of heart chambers, our research underscores the importance of chamber-specific cardiomyocytes for innovative and targeted treatments addressing diseases such as atrial fibrillation and cardiac hypertrophy. Get the paper here: https://lnkd.in/erGjVvaq #atrialfibrillation #cardiachypertrophy #iPS #cardiomyocytes #diseasemodel #publication #contractility #FLEXcyte96

CALCIO is a prospective, observational cohort study that is collecting real-world data on the use of intravascular lithotripsy (IVL) with the Shockwave Medical IVL system (Shockwave Medical, Inc.) to disrupt vascular calcifications in patients with chronic limb-threatening ischemia (CLTI). The study was initiated and is co-chaired by Dr. Raman uberoi, Prof. Peter Reimer and Prof. Christoph Binkert. CALCIO started patient enrolment on July 15, 2024, with the goal of recruiting 400 CLTI patients over the next two years. Learn more about CALCIO via CIRSE Insider! ➡️ https://t.ly/fkULP #CIRSEinsider #interventionalradiology Next Research

ASIA 2024 PRECOURSES - REGISTER NOW! Researchers, Clinicians, and other SCI Professionals are invited to join us for the 2024 Annual Scientific Meeting, May 20-23 in San Juan, Puerto Rico. The conference will include three-and-a-half days of Precourses, Courses, General Sessions, Posters, and endless networking.  Precourse 1 DME and Accessibility: The Essence for Maintaining Autonomy and Independence of People with a Spinal Cord Injury A collaborative one-day workshop organized by three ASIA Committees (Americas, Rehabilitation Standards and Education) to enhance the knowledge of spinal cord injury care for any provider involved in the care of this patient population in the United States and abroad. Precourse 2 From Molecules to Movement – Scope, Utility, and Application of Biomarkers for SCI Clinical Trials and the Development of SCI Precision Medicine Spinal Cord Outcomes Partnership Endeavor (SCOPE) This pre-course is tailored for SCI clinicians, preclinical and clinical researchers as well as biomarker scientists